Research, Select, & Monitor Saturday, August 18, 2018 12:26:20 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Sorrento Therapeutics, Inc.$5.35$.05.94%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Sorrento Therapeutics, Inc. has an overall rank of 1890 out of 7022 stocks based on 9 positive rankings and 4 negative rankings.

Positive Rankings
Historic Revenue Growth
Sorrento Therapeutics rank is 14
Target Prices
The average analysts' target price is $14.25 for Sorrento Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Sorrento Therapeutics is ranked 17.
Sorrento Therapeutics has a PEG Value of $7.42. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 38.75% in the next year. Among companies with a PEG Value above the current stock price, Sorrento Therapeutics is ranked 453.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Sorrento Therapeutics is ranked 457.
10 Day Gain
Sorrento Therapeutics rank is 575
Sorrento Therapeutics rank is 2164
Highest ROA
Sorrento Therapeutics rank is 2294
Highest Net Margin
Sorrento Therapeutics rank is 2508
Highest ROE
Sorrento Therapeutics rank is 2724
Negative Rankings
Negative Revenue Estimate
Sorrento Therapeutics rank is 3
90 Day Loss
Sorrento Therapeutics rank is 1099
Sorrento Therapeutics rank is 1986
Sorrento Therapeutics rank is 2333

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2018 All rights reserved.